Home > Healthcare > Pharmaceuticals > Finished Drug Form > Corticosteroids Market

Corticosteroids Market Share

Report ID: GMI8378
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Corticosteroids Market Share

The corticosteroids industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced product based on different technologies is among a key market strategy. Some of the leading industry players including AbbVie Inc., Astellas Pharma Inc., Novartis AG, Pfizer Inc., and Eli Lilly and Company among others have a notable presence in the market.

Corticosteroids Market Companies

Some of the eminent market participants operating in the corticosteroids industry include:

AbbVie Inc.
Astellas Pharma Inc.
AstraZeneca plc
Bausch Health Companies Inc.
Bayer AG
Cipla Limited
Eli Lilly and Company
GlaxoSmithKline plc
Lupin Limited
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Sanofi S.A.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of corticosteroids reached USD 5.2 billion in 2023 and is set to cross USD 9.8 billion by 2032, owing to the rising incidence of chronic diseases and the increasing prevalence of cancers worldwide.

The glucocorticoids segment is set to reach USD 8.9 billion by 2032, due to an increase in the prevalence of conditions like rheumatoid arthritis, inflammatory bowel disease, asthma, and allergic reactions.

North America market was valued at USD 1.9 billion in 2023, attributed to regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and Health Canada, actively supporting R&D initiatives in the region.

AbbVie Inc., Astellas Pharma Inc., AstraZeneca plc, Bausch Health Companies Inc., Bayer AG, Cipla Limited, Eli Lilly and Company, GlaxoSmithKline plc, Lupin Limited, Merck & Co., Inc., Novartis AG, Pfizer Inc., and Sanofi S.A., are some of the major corticosteroids companies worldwide.